Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021

SELL
$4.03 - $7.57 $7,902 - $14,844
-1,961 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$6.8 - $9.16 $646 - $870
-95 Reduced 4.62%
1,961 $14,000
Q4 2020

Feb 12, 2021

BUY
$5.29 - $9.1 $2,904 - $4,995
549 Added 36.43%
2,056 $16,000
Q3 2020

Nov 13, 2020

SELL
$5.41 - $9.45 $3,370 - $5,887
-623 Reduced 29.25%
1,507 $14,000
Q2 2020

Aug 14, 2020

BUY
$4.25 - $8.46 $2,120 - $4,221
499 Added 30.59%
2,130 $18,000
Q4 2019

Feb 13, 2020

BUY
$7.01 - $11.01 $2,607 - $4,095
372 Added 29.55%
1,631 $12,000
Q4 2018

Feb 15, 2019

BUY
$7.88 - $17.98 $9,920 - $22,636
1,259 New
1,259 $13,000

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.